We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
65 hedge funds and large institutions have $153M invested in Larimar Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,933% more call options, than puts
Call options by funds: $121K | Put options by funds: $3K
27% more capital invested
Capital invested by funds: $120M → $153M (+$32.8M)
0% more funds holding
Funds holding: 65 → 65 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0.67% less ownership
Funds ownership: 90.2% → 89.52% (-0.67%)
25% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 24
Holders
65
Holders Change
–
Holders Change %
0%
% of All Funds
1.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
18
Reduced
24
Closed
8
Calls
$121K
Puts
$3K
Net Calls
+$118K
Net Calls Change
+$97K
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$3.84M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.58M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.99M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$695K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$557K |
